GlaxoSmithKline Consumer Healthcare Limited reported audited earnings results for the fourth quarter and full year ended March 31, 2018. For the quarter, the company reported revenue from operations of INR 11,795.8 million compared to INR 12,097.0 million a year ago. Total Income was INR 12,637.5 million compared to INR 12,797.2 million a year ago. Profit before tax was INR 3,188.9 million compared to INR 2,694.6 million a year ago. Profit for the period was INR 2,118.1 million compared to INR 1,758.8 million a year ago. Total comprehensive income for the period was INR 2,200.9 million compared to INR 1,786.1 million a year ago. Earnings per basic and diluted share (of INR 10 each) (not annualised) were INR 50.36 compared to INR 41.82 a year ago. For the full year, the company reported revenue from operations of INR 43,770.5 million compared to INR 44,259.1 million a year ago. Total income was INR 46,344.6 million compared to INR 46,649.7 million a year ago. Profit before tax was INR 10,743.6 million compared to INR 10,104.2 million a year ago. Profit for the period was INR 7,001.0 million compared to INR 6,566.8 million a year ago. Total comprehensive income for the period was INR 7,167.7 million compared to INR 6,782.8 million a year ago. Earnings per share (of INR 10 each) (not annualised) basic and diluted were INR 165.47 compared to INR 156.15 a year ago.